2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia.

Landmesser, Ulf; Chapman, M John; Stock, Jane K; Amarenco, Pierre; Belch, Jill J F; Borén, Jan; Farnier, Michel; Ference, Brian A; Gielen, Stephan; Graham, Ian; Grobbee, Diederick E; Hovingh, G Kees; Lüscher, Thomas F; Piepoli, Massimo F; Ray, Kausik K; Stroes, Erik S; Wiklund, Olov; Windecker, Stephan; Zamorano, Jose Luis; Pinto, Fausto; ... (2018). 2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia. European Heart Journal, 39(14), pp. 1131-1143. Oxford University Press 10.1093/eurheartj/ehx549

[img] Text
ehx549.pdf - Published Version
Restricted to registered users only until 17 October 2020.
Available under License Publisher holds Copyright.

Download (854kB) | Request a copy

Item Type:

Journal Article (Review Article)

Division/Institute:

04 Faculty of Medicine > Department of Cardiovascular Disorders (DHGE) > Clinic of Cardiology

UniBE Contributor:

Windecker, Stephan

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0195-668X

Publisher:

Oxford University Press

Language:

English

Submitter:

Nadia Biscozzo

Date Deposited:

08 Feb 2018 13:48

Last Modified:

25 Apr 2018 11:37

Publisher DOI:

10.1093/eurheartj/ehx549

PubMed ID:

29045644

BORIS DOI:

10.7892/boris.107407

URI:

https://boris.unibe.ch/id/eprint/107407

Actions (login required)

Edit item Edit item
Provide Feedback